0001209191-23-018017.txt : 20230310 0001209191-23-018017.hdr.sgml : 20230310 20230310195447 ACCESSION NUMBER: 0001209191-23-018017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230309 FILED AS OF DATE: 20230310 DATE AS OF CHANGE: 20230310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGrath Yvonne CENTRAL INDEX KEY: 0001816213 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39401 FILM NUMBER: 23725345 MAIL ADDRESS: STREET 1: C/O ITEOS THERAPEUTICS, INC. STREET 2: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iTeos Therapeutics, Inc. CENTRAL INDEX KEY: 0001808865 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 ARSENAL STREET STREET 2: BLDG 312, FLOOR 3, SUITE 301 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 857-204-4583 MAIL ADDRESS: STREET 1: 321 ARSENAL STREET STREET 2: BLDG 312, FLOOR 3, SUITE 301 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-09 0 0001808865 iTeos Therapeutics, Inc. ITOS 0001816213 McGrath Yvonne 321 ARSENAL STREET WATERTOWN MA 02472 0 1 0 0 Chief Scientific Officer Stock Option (Right to Buy) 16.66 2023-03-09 4 A 0 130000 0.00 A 2033-03-09 Common Stock 130000 130000 D This stock option shall vest over four years, with 25% vesting on March 9, 2024 and thereafter in equal monthly installments over the next 36 months, subject to the reporting person's continued service to the Issuer. /s/ Adi Osovsky, as Attorney-in-Fact 2023-03-10